Glucoside derivatives and uses thereof as SGLT inhibitors

Details for Australian Patent Application No. 2009294613 (hide)

Owner Novartis AG

Inventors Palle, P. Venkata; Bhuniya, Debnath; Reddy, Dumbala Srinivas; Kurhade, Suresh Eknath

Agent Davies Collison Cave

Pub. Number AU-A-2009294613

PCT Pub. Number WO2010/031820

Priority 2200/DEL/2008 19.09.08 IN

Filing date 17 September 2009

Wipo publication date 25 March 2010

International Classifications

C07D 309/10 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 31/351 (2006.01) - not condensed with another ring

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/031820 Priority application(s): WO2010/031820

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009294618-Methods and compositions for the treatment of cancer

2009294612-Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.